Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Pharmacological Approaches to Delaying Disability Progression in Patients with Multiple Sclerosis.
Circulating Follicular Regulatory T Cells Are Defective in Multiple Sclerosis.
Heterogeneous spectrum of neuropathies in Waldenström's macroglobulinemia: a diagnostic strategy to optimize their management.
A gene expression study denies the ability of 25 candidate biomarkers to predict the interferon-beta treatment response in multiple sclerosis patients.
OCT and Visual Field Changes as Useful Markers for Follow-up of Axonal Loss in Multiple Sclerosis in Egyptian Patients.
How similar are commonly combined criteria for EDSS progression in multiple sclerosis?
Erratum to: 'Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial'.
Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications.
Multiple sclerosis: potential risk factors in childhood and adolescence.
Tellurium Compound AS101 Ameliorates Experimental Autoimmune Encephalomyelitis by VLA-4 Inhibition and Suppression of Monocyte and T Cell Infiltration into the CNS.
Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis.
Physiological Dynamics in Demyelinating Diseases: Unraveling Complex Relationships through Computer Modeling.
Interaction Study of Phospholipid Membranes with an N-Glucosylated β-Turn Peptide Structure Detecting Autoantibodies Biomarkers of Multiple Sclerosis.
Microglia and astrocyte activation in the frontal cortex of rats with experimental autoimmune encephalomyelitis.
Pharmacogenetics of multiple sclerosis: personalized therapy with immunomodulatory drugs.
Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression index.
The impact of microglial activation on blood-brain barrier in brain diseases.
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses.
The Significance of Matrix Metalloproteinases in the Immunopathogenesis and Treatment of Multiple Sclerosis.
Cyclin-Dependent Kinase 5 Mediates Adult OPC Maturation and Myelin Repair through Modulation of Akt and GsK-3β Signaling.
Gait characteristics of multiple sclerosis patients in the absence of clinical disability.
Multiple perspectives on the health service need, use, and variability among older adults with multiple sclerosis.
Progressive multifocal leukoencephalopathy in an immunocompetent patient?
Assessments of nursing home guidelines for quality of care provided to residents with multiple sclerosis.
Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project.

Pages